Medicare AdvantageReimbursementMedium impact
MA00.058, Reimbursement of Surgical Pathology Services for Prostate Biopsy
Independence Blue Cross·Pathology, Urology·Claims & Billing
Effective date
Mar 2, 2026
We identified it
Jun 19, 2026
Summary
A new Medicare Advantage policy MA00.058 specifically addresses reimbursement for surgical pathology services related to prostate biopsies. This policy establishes coverage and billing guidelines for pathology interpretation of prostate biopsy specimens.
Action Required
Before March 2, 2026: Billing team must review and implement new reimbursement guidelines for prostate biopsy pathology services under Medicare Advantage plans. Update billing procedures to align with MA00.058 requirements. Coordinate with pathology department and urology providers to ensure proper documentation and coding compliance for prostate biopsy specimens.